Notably, it is reported that IL-38 increased significantly in influenza and COVID-19 patients and may function as a suppressor cytokine that inhibits IL-1, IL-6 and TNF-α in COVID patients (116, 117). This evidence concerns the gene IL6 and COVID-19.